These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 15386312)
1. Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making. Teixeira MR; Ribeiro FR; Eknaes M; Waehre H; Stenwig AE; Giercksky KE; Heim S; Lothe RA Cancer; 2004 Oct; 101(8):1786-93. PubMed ID: 15386312 [TBL] [Abstract][Full Text] [Related]
2. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865 [TBL] [Abstract][Full Text] [Related]
3. 8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects. Ribeiro FR; Jerónimo C; Henrique R; Fonseca D; Oliveira J; Lothe RA; Teixeira MR Clin Cancer Res; 2006 Jul; 12(13):3961-70. PubMed ID: 16818693 [TBL] [Abstract][Full Text] [Related]
4. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067 [TBL] [Abstract][Full Text] [Related]
5. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134 [TBL] [Abstract][Full Text] [Related]
6. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients. Ribeiro FR; Henrique R; Martins AT; Jerónimo C; Teixeira MR Eur Urol; 2007 Jul; 52(1):116-25. PubMed ID: 17070983 [TBL] [Abstract][Full Text] [Related]
8. Genomic aberrations in carcinomas of the uterine corpus. Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002 [TBL] [Abstract][Full Text] [Related]
9. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries. Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429 [TBL] [Abstract][Full Text] [Related]
10. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray. Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025 [TBL] [Abstract][Full Text] [Related]
11. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways. Noutomi Y; Oga A; Uchida K; Okafuji M; Ita M; Kawauchi S; Furuya T; Ueyama Y; Sasaki K J Pathol; 2006 Sep; 210(1):67-74. PubMed ID: 16767698 [TBL] [Abstract][Full Text] [Related]
12. Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis. Diep CB; Parada LA; Teixeira MR; Eknaes M; Nesland JM; Johansson B; Lothe RA Genes Chromosomes Cancer; 2003 Feb; 36(2):189-97. PubMed ID: 12508247 [TBL] [Abstract][Full Text] [Related]
13. Chromosomal changes during development and progression of prostate adenocarcinomas. Zitzelsberger H; Engert D; Walch A; Kulka U; Aubele M; Höfler H; Bauchinger M; Werner M Br J Cancer; 2001 Jan; 84(2):202-8. PubMed ID: 11161378 [TBL] [Abstract][Full Text] [Related]
14. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy. Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens. Rogatsch H; Moser P; Volgger H; Horninger W; Bartsch G; Mikuz G; Mairinger T Hum Pathol; 2000 Sep; 31(9):1102-7. PubMed ID: 11014578 [TBL] [Abstract][Full Text] [Related]
16. Genetic changes in pT2 and pT3 prostate cancer detected by comparative genomic hybridization. Fukasawa S; Kino M; Kobayashi M; Suzuki H; Komiya A; Imamoto T; Hirokawa Y; Shiraishi T; Takiguchi M; Ishida H; Shindo T; Seki N; Ichikawa T Prostate Cancer Prostatic Dis; 2008; 11(3):303-10. PubMed ID: 17923855 [TBL] [Abstract][Full Text] [Related]
17. Gain of chromosome 8q: a potential prognostic marker in resectable adenocarcinoma of the pancreas? Schleicher C; Poremba C; Wolters H; Schäfer KL; Senninger N; Colombo-Benkmann M Ann Surg Oncol; 2007 Apr; 14(4):1327-35. PubMed ID: 17235717 [TBL] [Abstract][Full Text] [Related]
18. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens. Gonzalgo ML; Pavlovich CP; Lee SM; Nelson WG Clin Cancer Res; 2003 Jul; 9(7):2673-7. PubMed ID: 12855646 [TBL] [Abstract][Full Text] [Related]
19. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma. Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376 [TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of multifocal prostate cancer by comparative genomic hybridization. Kobayashi M; Ishida H; Shindo T; Niwa S; Kino M; Kawamura K; Kamiya N; Imamoto T; Suzuki H; Hirokawa Y; Shiraishi T; Tanizawa T; Nakatani Y; Ichikawa T Prostate; 2008 Dec; 68(16):1715-24. PubMed ID: 18781578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]